Irritable Bowel Syndrome Trial, Recruiting NCT06473454 Sponsor: Istanbul Saglik Bilimleri University Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT06473454
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You meet a specific set of guidelines used to diagnose irritable bowel syndrome or similar gut conditions, known as the Rome IV criteria (confirm with trial site)
  • You are willing to take part and can sign a written consent form

Who may not be able to join:

  • You do not want to take part in the study
  • You have been diagnosed with a psychiatric (mental health) illness
  • You have a bone, joint, nerve, heart, or lung condition that could make the study procedures unsafe for you
  • You have a condition or posture-related issue that could put you at risk of injury during the study (confirm with trial site)
  • You have significant muscle tightness that would prevent you from completing certain physical tests (confirm with trial site)
  • You regularly take laxatives
  • You have been diagnosed with diabetes or another metabolic condition that affects your digestive system
  • You have a history of Inflammatory Bowel Disease (IBD), colon cancer, or have had part of your colon surgically removed
  • You have taken antibiotics or probiotics in the last 3 months
  • You take medications that slow down or affect how your gut moves, such as anticholinergic drugs, opiates, or morphine-based medicines
  • You have been diagnosed with coeliac disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Saglik Bilimleri University
Registry
ClinicalTrials.gov
Start date
20 July 2024
Est. completion
15 December 2024

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

IBS Quality of Life Scale; Gastrointestinal Symptom Assessment Scale (GSDS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov